Compare EARN & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EARN | APYX |
|---|---|---|
| Founded | 2012 | 1982 |
| Country | United States | United States |
| Employees | 160 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 179.2M | 169.6M |
| IPO Year | 2012 | 1995 |
| Metric | EARN | APYX |
|---|---|---|
| Price | $4.81 | $4.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $5.38 | ★ $6.50 |
| AVG Volume (30 Days) | ★ 402.6K | 223.5K |
| Earning Date | 06-16-2026 | 05-07-2026 |
| Dividend Yield | ★ 20.51% | N/A |
| EPS Growth | N/A | ★ 19.40 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.69 | $11.93 |
| Revenue Next Year | $19.57 | $11.01 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.27 | $1.41 |
| 52 Week High | $6.08 | $4.50 |
| Indicator | EARN | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 53.39 | 58.00 |
| Support Level | $4.54 | $3.18 |
| Resistance Level | $5.36 | $4.29 |
| Average True Range (ATR) | 0.09 | 0.37 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 64.65 | 86.97 |
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.